4.6 Article

Short course corticosteroid treatment and closed-loop insulin delivery system: The experience of the DBLG1 pre-launch

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-Month Follow-up

Coralie Amadou et al.

Summary: The study analyzed the safety and efficacy of the DBLG1 hybrid closed-loop system in patients with type 1 diabetes in real-world conditions. After 6 months, there was a significant improvement in glycemic control, with a decrease in HbA(1c) and an increase in TIR, without any serious adverse events reported.

DIABETES CARE (2021)